《大行報告》高盛上調普拉達(01913.HK)目標價至61.5元 評級「買入」
高盛發表研究報告,指普拉達(01913.HK)舉行資本市場日,重申其長遠策略,包括針對產品質素、直銷渠道、有效和可持續生產等,相信公司正處於拐點,自2017年轉變策略起,其目標都有效落實,帶動品牌價值以及盈利擴張。
該行指出,公司新中期目標收入為45億歐元,EBIT利潤率約20%,都有助推動該行預期,同時公司第三季增長強勁,以固定匯率計零售銷售較2019年同期增18%,高於該行預期,毛利率由上半年的74.3%擴至76%,管理層亦有信心銷售增長持續至第四季。高盛上調其2021至2022財年EBIT預測5%至8%,目標價由56元升至61.5元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.